Beclazone Easi-Breathe discontinued

Teva has ceased supply of all strengths of Beclazone Easi-Breathe (beclometasone dipropionate) inhalers, in line with the Montreal Protocol requirement for all CFC-containing beclometasone products to be phased out by 2010.

Qvar Easi-Breathe and Salamol Easi-Breathe are unaffected. Patients using Beclazone Easi-Breathe will need to be transferred to a suitable alternative.

Further information: Teva

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Asthma drug hailed as first non-hospital treatment for COVID-19

Asthma drug hailed as first non-hospital treatment for COVID-19

Inhaled budesonide is the first widely available, inexpensive...

Drug shortages - live tracker

Drug shortages - live tracker

Use our constantly updated shortages tracker to check...

Live updates: Coronavirus (COVID-19) in the UK

Live updates: Coronavirus (COVID-19) in the UK

Use our timeline to follow the latest coronavirus developments...

Under-30s to be offered alternative to AstraZeneca COVID-19 vaccine after reports of rare blood clots